Application of chiral recyclable catalysts in asymmetric catalysis

Han, GuiPing; Ren, WenQi; Zhang, ShengYong; Zuo, ZhenYu; He, Wei

doi:10.1039/d4ra01050g

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Preprint1

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 133 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Development of anticancer and antidiabetic polyhydroquinoline derivatives by solvent-free heterocyclization

Patil,

Mane,

Mohite

et al. 2024

J Nanopart Res

View full text Add to dashboard Cite

Development of anticancer and antidiabetic polyhydroquinoline derivatives by solvent-free heterocyclization

Patil,

Mane,

Mohite

et al. 2024

J Nanopart Res

View full text Add to dashboard Cite

Sustainable development of anticancer and antidiabetic derivatives by solvent-free heterocyclization

Patil,

Mane,

Mohite

et al. 2024

Preprint

View full text Add to dashboard Cite

Herein we have developed a heterogeneous catalyst for synthesizing various anticancer and antidiabetic derivatives via heterocyclic synthesis under solvent-free conditions at mild temperatures. This approach eliminates the need for complex cleanup or column chromatography, thus minimizing waste production. Moreover, the catalyst can be recovered and reused up to multiple times without compromising product yields, demonstrating its sustainability and environmental friendliness. Additionally, we evaluated each synthetic derivative for anticancer and antidiabetic activities. Initial assays revealed that certain derivatives exhibit promising inhibition against human breast cancer cells (MCF7), suggesting their potential as lead structures for future anticancer agents. Furthermore, the synthesized derivatives were assessed for antidiabetic activity, showing superior efficacy. Notably, derivatives containing –H, –CH3, and –OCH3 substituents demonstrated excellent anticancer activity compared to 5-fluorouracil (5-FU), while derivatives containing –H and –Br substituents showed notable antidiabetic activities over acarbose, highlighting their therapeutic potential. Thus, our study presents a highly effective and sustainable approach for synthesizing polyhydroquinoline derivatives, emphasizing the catalyst's dual benefits in organic synthesis and medicinal chemistry applications.

show abstract

Application of chiral recyclable catalysts in asymmetric catalysis

Abstract: Chiral drugs hold a significant position within the contemporary pharmaceutical market, and the chiral catalysts play a crucial role in their synthesis.

Cited by 2 publications

References 133 publications

Development of anticancer and antidiabetic polyhydroquinoline derivatives by solvent-free heterocyclization

Development of anticancer and antidiabetic polyhydroquinoline derivatives by solvent-free heterocyclization

Sustainable development of anticancer and antidiabetic derivatives by solvent-free heterocyclization

Contact Info

Product

Resources

About